treatment for PTSD in veterans Assignment | Custom Essay Services

The paper is about use of Psilocybin (pharmcoligcal approach) as treatment for PTSD in veterans. I have found some articles to use already to help. Paper should cover how the pharmacological approach to therapy is proving better results than standard therapy, how veteran treatment is restricted to FDA approved drugs, and connect the idea research should be continued and used to treat PTSD in combat veterans as the current climate of treatment is not working. current rubric is not current, paper requires 4 sources minimum and 6 pages.

Alexander W. (2012). Pharmacotherapy for Post-traumatic Stress Disorder In Combat Veterans: Focus on                 Antidepressants and Atypical Antipsychotic Agents. P & T : a peer-reviewed journal for formulary                 management, 37(1), 32–38.

Barrett, F.S., Doss, M.K., Sepeda, N.D. et al. Emotions and brain function are altered up to one month   after a single high dose of psilocybin. Sci Rep 10, 2214 (2020). https://doi.org/10.1038/s41598-               020-59282-y

Carhart-Harris, R., Leech, R., Williams, T., Erritzoe, D., Abbasi, N., Bargiotas, T., . . . Nutt, D. (2012).             Implications for psychedelic-assisted psychotherapy: Functional magnetic resonance imaging              study with psilocybin. British Journal of Psychiatry, 200(3), 238-244.   :10.1192/bjp.bp.111.103309

Erwin Krediet, Tijmen Bostoen, Joost Breeksema, Annette van Schagen, Torsten Passie, Eric Vermetten,                 Reviewing the Potential of Psychedelics for the Treatment of PTSD, International Journal of                 Neuropsychopharmacology, , pyaa018, https://doi.org/10.1093/ijnp/pyaa018

Grob, Charles & Bossis, Anthony & Griffiths, Roland. (2013). Use of the Classic Hallucinogen Psilocybin    for Treatment of Existential Distress Associated with Cancer. 10.1007/978-1-4614-4866-2_17.

Mithoefer, Michael & Grob, Charles & Brewerton, Timothy. (2016). Novel psychopharmacological            therapies for psychiatric disorders: Psilocybin and MDMA. The Lancet Psychiatry. 3.    10.1016/S2215-0366(15)00576-3.

Points Earned:
APA Style (0-40 pts):
Abstract (0-5pts): ____
Citations (0-10pts): ____
Cover Page (0-5pts): ____
Running Head (0-5pts): ____
Page Numbers (0-5 pts): ____
Reference Page (0-10pts): ____
Grammar/Spelling (0-15 pts): _____
Organization/Style (0-15 pts): _____
Quality of Information (0-30 pts): _____
 Supported by relevant/legitimate sources
 Information not found in the textbook
 Current research (No more than 15 years old)
Total Points Earned: _____
Deductions:
References (3 needed, -5 per missing reference): _____
Pages (5 needed, -10 per missing page): ____
Similar to presentation (-20): ____
Little/no attempt at APA style (-10): ____
Inappropriate Topic (-50): ____
Total Deductions: ______
Final Paper Grade: _____